Kintor Pharmaceutical Limited KNTPF
Set alert
0.16 USD -0.08 -35.11%
At close · Nov 2
0.5652 Day range 0.5652
0.1542 52-week range 0.5708
- YTD
- -27.45%
- 1 year
- -41.70%
- Open
- 0.5652
- Prev close
- 0.2415
- Mkt cap
- 76.61M
- Vol
- 100
- Avg vol
- 2.56K
- EPS
- -0.06
- P/E
- 0.00
More statistics
- Low
- 0.5652
- High
- 0.5652
2Y chart
Signals (52)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 2026 | 1 day ago |
| RSI: Oversold | Nov 2, 2026 | 1 day ago |
| MACD: Sell Signal | Sep 29, 2026 | 1 month ago |
| SMA: Bullish | Sep 8, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 8, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 3, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 11, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 29, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 27, 2026 | 3 months ago |
| SMA: Bearish | Jul 1, 2026 | 4 months ago |
| SMA: Bearish | Jul 1, 2026 | 4 months ago |
| MACD: Sell Signal | Jul 1, 2026 | 4 months ago |
| RSI: Oversold | Jul 1, 2026 | 4 months ago |
| SMA: Bullish | Jun 15, 2026 | 4 months ago |
| SMA: Bullish | Jun 15, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 12, 2026 | 4 months ago |
| SMA: Bearish | May 28, 2026 | 5 months ago |
| RSI: Oversold | May 28, 2026 | 5 months ago |
| MACD: Sell Signal | May 14, 2026 | 5 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
Newest 20 of 52.
News
- Kintor Pharma Announces the Approval for Phase II Clinical Trial of Hedgehog/SMO Inhibitor GT1708F for Treatment of IPF in China
- Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China
- Kintor Pharma Announces Completion of First Patient Enrollment in Long-term Safety Phase III Trial of KX-826 for Treatment of AGA
Your note
Sign in to keep a note on KNTPF — it syncs with the Stock Master app.